Cargando…
Immune Dysfunction and Multiple Treatment Modalities for the SARS-CoV-2 Pandemic: Races of Uncontrolled Running Sweat?
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global pandemic threat with more than 11.8 million confirmed cases and more than 0.5 million deaths as of 3 July 2020. Given the lack of definitive pharmaceutical interventions against SARS-CoV-2, multiple therapeutic strategies a...
Autores principales: | Kothari, Ashish, Singh, Vanya, Nath, Uttam Kumar, Kumar, Sandeep, Rai, Vineeta, Kaushal, Karanvir, Omar, Balram Ji, Pandey, Atul, Jain, Neeraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563789/ https://www.ncbi.nlm.nih.gov/pubmed/32846906 http://dx.doi.org/10.3390/biology9090243 |
Ejemplares similares
-
Association of multidrug resistance behavior of clinical Pseudomonas aeruginosa to pigment coloration
por: Kothari, Ashish, et al.
Publicado: (2022) -
Potential Synergistic Antibiotic Combinations against Fluoroquinolone-Resistant Pseudomonas aeruginosa
por: Kothari, Ashish, et al.
Publicado: (2022) -
Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis
por: Jangra, Anshika, et al.
Publicado: (2022) -
Age of Antibiotic Resistance in MDR/XDR Clinical Pathogen of Pseudomonas aeruginosa
por: Kothari, Ashish, et al.
Publicado: (2023) -
Can you run your business with blood, sweat, and tears? volume II: sweat
por: Elkins-Jarrett, Stephen, et al.
Publicado: (2018)